$2.39
0.083.46%
At close: Aug 5, 5:00 PM EST
$2.35
-0.04-1.67%
After Hours: 4:25 PM EST
Atossa Therapeutics Inc Earnings Estimates
ATOSNASDAQ
Atossa Therapeutics Earnings Estimates, EPS & Revenue | NASDAQ:ATOS
Atossa Therapeutics (ATOS) is scheduled to report Q2 earnings on August 18, 2026. Analysts estimate EPS of $-1.09 and quarterly revenue of N/A.
In the most recent quarter (Q1), Atossa Therapeutics reported EPS of $-1.11, beating estimates of $-1.22 by 0.09%. Revenue came in at $0, meeting the estimate of $0 by 0.00%.
Atossa Therapeutics has beaten EPS estimates in 2 consecutive quarters.
Over the last 4 quarters, Atossa Therapeutics has averaged an EPS surprise of 0.31% and a revenue surprise of 0.00%.
Earnings Date
Aug 18
EPS Estimate
$-1.090
Quarterly Revenue Estimate
–
Annual Revenue
–
as of Mar 31
Atossa Therapeutics Earnings History
Analyze the earnings history of Atossa Therapeutics using advanced sorting and filters.
Atossa Therapeutics (ATOS) Earnings Per Share
The chart below shows Atossa Therapeutics's reported EPS compared to analyst estimates over recent quarters.
Atossa Therapeutics (ATOS) Revenue
The chart below shows Atossa Therapeutics's reported revenue compared to analyst estimates over recent quarters.
FAQ
When is Atossa Therapeutics (NASDAQ:ATOS) reporting earnings?
Atossa Therapeutics (ATOS) is scheduled to report earnings on August 18, 2026. The last reported earnings were for reported on May 8, 2026 for Q1.
What were the latest earnings per share (EPS) for Atossa Therapeutics (NASDAQ:ATOS)?
The Actual EPS was $-1.11, which beat the estimate of $-1.22.
What were Atossa Therapeutics’s (NASDAQ:ATOS) revenues?
The Actual Revenue was $0, which hit the estimate of $0.
